Healthcare Distribution Alliance – Patients Move Us.
Share Print



Results: 27 Articles found.
  • HDA Statement on Review of Annual Production Quotas for Opioids
    March 2, 2018

    HDA President and CEO John M. Gray released the following statement in response to Attorney General Jeff Sessions' recent memo regarding opioid production quotas.

  • The Opioid Epidemic Requires A Greater Focus on Education and Awareness
    March 2, 2018

    As the country looks to reverse the harmful trend of opioid addiction, the need for education and awareness around the safe use of pain treatments has never been clearer.

  • HDA Statement on Department of Justice Opioid Efforts
    February 27, 2018

    Today, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued a statement in response to new efforts by the Department of Justice to address the opioid epidemic.

  • HDA Calls for “Universal” Suspicious Orders Database to Enhance Efforts Against Diversion, Misuse
    February 22, 2018

    In a letter to the Drug Enforcement Administration (DEA) Acting Administrator Robert Patterson, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray called for a “universal” database to support enhanced monitoring of suspicious orders of controlled substances, including controlled opioid drugs. While the DEA has indicated that it currently is developing a suspicious orders database for its own use, HDA’s latest letter calls for the agency to share this data, and DEA’s advanced analytical tools, with state regulators and state/local law enforcement officials to improve information sharing and coordination.

  • Transitioning to Traceability — and a Verification Router Service Update
    February 16, 2018

    As an organization, HDA has been looking for new ways to communicate the work happening around DSCSA implementation with a broader audience beyond twice a year at our Traceability Seminar and Distribution Management Conference. Beginning this month, the HDA blog is expanding to feature traceability/Drug Supply Chain Security Act (DSCSA) updates as well as HDA perspectives on a variety of related issues throughout the year.

Website design and development by, inc
© 2018 Healthcare Distribution Alliance. All rights reserved.
HDA: M | C | D | NF | O365